Health Care & Life Sciences » Pharmaceuticals | CTT Pharmaceutical Holdings Inc.

CTT Pharmaceutical Holdings Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
-
-
-
-
40.00
27.20
SG&A Expense
92.20
672.20
1,233.10
639.90
1,412.00
1,733
EBIT
92.20
672.20
-
-
1,372.00
1,708
Unusual Expense
-
900.00
-
-
-
-
Non Operating Income/Expense
16.60
-
15.10
2.60
8.60
1.60
Pretax Income
110.50
227.80
1,218.00
642.50
1,380.70
1,728
Consolidated Net Income
110.50
227.80
1,218.00
642.50
1,380.70
1,728
Net Income
110.50
227.80
1,218.00
642.50
1,380.70
1,728
Net Income After Extraordinaries
110.50
227.80
1,218.00
642.50
1,380.70
1,728
Net Income Available to Common
110.50
227.80
1,218.00
642.50
1,380.70
1,728
EPS (Basic)
0.10
0.01
0.06
0.03
0.04
0.04
Basic Shares Outstanding
941.40
16,338.90
21,319.30
23,866.00
38,722.90
47,073.70
EPS (Diluted)
0.12
0.01
0.06
0.03
0.04
0.04
Diluted Shares Outstanding
941.40
16,338.90
21,319.30
23,866.00
38,722.90
47,073.70
EBITDA
92.20
672.20
1,233.10
639.90
1,372.00
-
Non-Operating Interest Income
1.60
-
-
-
-
-

About CTT Pharmaceutical Holdings

View Profile
Address
35 Galbraith Drive
Stoney Creek Ontario L9G 4X6
Canada
Employees -
Website http://www.cttpharmaceuticals.com
Updated 07/08/2019
CTT Pharmaceutical Holdings, Inc. is a development stage company. The firm specializes in drug delivery systems technology within the pharmaceutical industry. Is product include Medwafe, Cannawafe, and Vetwafe.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.